《藥物安全》是唯一一本涵蓋藥物警戒、藥物流行病學(xué)和效益風(fēng)險評估等學(xué)科的國際評論期刊。藥物安全組織的同行評審委托文章結(jié)構(gòu)化計劃確保了所有主題的全面覆蓋。高質(zhì)量的原始研究集中在藥物治療安全問題的臨床意義也發(fā)表了。藥物安全專門對個別藥物或藥物類別的流行病學(xué)、臨床特征、預(yù)防和不良反應(yīng)管理進(jìn)行最終審查。利益風(fēng)險評估為您提供對特定疾病中藥物的不良反應(yīng)和療效數(shù)據(jù)的深入審查。藥物安全性還包括對藥物使用特別是“高危”患者群體的審查，以及對藥物警戒、風(fēng)險最小化和藥物差錯預(yù)防的當(dāng)前思維的概念審查。文章側(cè)重于確保最安全地使用藥物的實際方面，包括對不良反應(yīng)的分析和解釋、上市后監(jiān)測和藥物流行病學(xué)。

Drug Safety is the only international review journal covering the disciplines of pharmacovigilance, pharmacoepidemiology and benefit-risk assessment. Drug Safety's structured programme of peer reviewed commissioned articles ensures comprehensive coverage of all topics. High quality original research focusing on the clinical implications of drug treatment safety issues is also published. Drug Safety specialises in definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual drugs or drug classes. Benefit-risk assessments provide you with an in-depth review of adverse effect and efficacy data for a drug in a specific disease. Drug Safety also features reviews covering drug use in particular 'at-risk' patient groups, and concept reviews of current thinking in pharmacovigilance, risk minimisation and medication error prevention. Articles focus on the practical aspects of ensuring the safest possible use of drugs, including analysis and interpretation of adverse effects, post-marketing surveillance and pharmacoepidemiology.